Orthopaedic economics concentrate in theatre utilisation, implant cost and post-operative follow-through. Drapto measures revenue by procedure and surgeon, tracks utilisation, and keeps insurer balances from ageing quietly.
The rehabilitation nobody completed was revenue too.
Orthopaedic pathways continue well past the operation. Patients who quietly stop attending post-operative and physiotherapy appointments represent both a clinical gap and a revenue one.
Joint replacement, arthroscopy, trauma and conservative management carry different margins. Reporting them separately with surgeon contribution ranked in department shows where the centre actually earns.
Follow-up appointments and physiotherapy courses that were booked but never completed show up on the patient timeline and in utilisation — both a care issue and a measurable revenue leak.
Measured utilisation makes list planning a decision rather than a habit.
Visible drop-off in post-operative and physiotherapy attendance is both a care and a revenue signal.
Ageing catches scheme payments before recovery odds collapse.
Contribution ranked within department, weighted by satisfaction, keeps performance reviews credible.
No. Inventory and clinical systems stay as they are; Drapto measures the revenue, collections and utilisation layer.
Attendance across the pathway is visible on the patient timeline, and no-show tracking prices the capacity lost.
Yes, with collection rate and ageing reported regardless of payer mix.
Yes. All three agents run on your own AI provider key and work from data already in your account. The Revenue Leakage Analyst calculates deterministically, so every figure it reports is verifiable against your own books.